Federal contract award
N0042124F0184
NEW TASK ORDER UNDER THE BOA FOR THE MMS SUPPORT SERVICES.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | NAVAL AIR WARFARE CENTER AIR DIV |
| NAICS | 336413 — Other Aircraft Parts and Auxiliary Equipment Manufacturing |
| PSC | K016 — Modification of Equipment: Aircraft Components and Accessories |
| Parent award / vehicle | N0042123G0005 |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | COST PLUS FIXED FEE |
| Obligations | $30.5M |
| Current contract value | $60.8M |
| Potential contract value / ceiling | $82.8M |
| Start date | Mar 25, 2024 |
| Current end date | Mar 24, 2027 |
| Potential end date | Mar 24, 2027 |
| Latest award activity | May 18, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 28 of 28 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jun 11, 2026 | P00027 | $2.8M | INCREMENTAL FUNDING |
| May 18, 2026 | P00026 | $1.3M | THE PURPOSE OF THIS MODIFICATION IS TO EXERCISE, UPDATE PERIOD OF PERFORMANCE FOR OPTION CLINS 2003, 2012, 2013, AND 2022, PROVIDE INCREMENTAL FUNDING, AND DE-OBLIGATE FUNDING. |
| Mar 23, 2026 | P00025 | $278.0K | THE PURPOSE OF THIS MODIFICATION IS TO PROVIDE INCREMENTAL FUNDING TO CLIN 1014. AS WELL AS FUND AND EXERCISE CLIN 2002. |
| Mar 5, 2026 | P00024 | $125.0K | THE PURPOSE OF THIS MODIFICATION IS TO PROVIDE INCREMENTAL FUNDING TO CLIN 1002. |
| Feb 5, 2026 | P00023 | $60.0K | THE PURPOSE OF THIS MODIFICATION IT TO PROVIDE INCREMENTAL FUNDING TO CLINS 1004 AND 1014, UPDATE TPOC, AND ADD COR. |
| Nov 13, 2025 | P00022 | $0 | THE PURPOSE OF THIS MODIFICATION IS TO MAKE ADMINISTRATIVE CORRECTIONS TO EXERCISE OPTION CLIN 1001, UPDATE CLIN 1001 POP, AND CORRECT SLIN 100101 CONTRACT TYPE. |
| Nov 7, 2025 | P00021 | $1.2M | IF CLIN 1001, 1002, AND 1012 |
| Sep 23, 2025 | P00020 | $100.0K | IF CLIN 1002 |
| Jul 28, 2025 | P00019 | $160.0K | THE PURPOSE OF THIS MODIFICATION IS TO EXERCISE AND INCREMENTALLY FUND OPTION CLINS 1003 AND 1013, AND UPDATE CLINS 1003 AND 1013 PERIOD OF PERFORMANCE. |
| Jul 17, 2025 | P00018 | $150.0K | THE PURPOSE OF THIS MODIFICATION IS TO PROVIDE INCREMENTAL FUNDING TO CLIN 1002. |
| Jun 30, 2025 | P00017 | $759.8K | THE PURPOSE OF THIS MODIFICATION IS TO DEOBLIGATE FUNDS FROM CLIN 1012 BY $610,000.00. |
| Jun 13, 2025 | P00016 | $59.9K | THE PURPOSE OF THIS MODIFICATION IS TO UPDATE CLIN 1022 PERIOD OF PERFORMANCE, EXERCISE OPTION CLIN 1022, AND INCREMENTALLY FUND CLINS 1002, 1012 AND 1022. |
| Jun 2, 2025 | P00015 | $1.0M | THE PURPOSE OF THIS MODIFICATION IS TO PROVIDE INCREMENTAL FUNDING TO CLINN 1012 AND PERFORM ADMINISTRATIVE CHANGES. |
| May 9, 2025 | P00014 | $2.6M | THE PURPOSE OF THIS MODIFICATION IS TO UPDATE CLIN 1004 AND 1014 PERIOD OF PERFORMANCE, INCORPORATE A CLAUSE VARIATION, EXERCISE AND INCREMENTALLY FUND OPTION CLINS 1004 AND 1014. |
| Apr 28, 2025 | P00013 | $250.0K | THE PURPOSE OF THIS MODIFICATION IS TO PROVIDE INCREMENTAL FUNDING TO CLIN 1002, AND PERFORM ADMINISTRATIVE CHANGES. |
| Apr 22, 2025 | P00012 | $794.4K | THE PURPOSE OF THIS MODIFICATION IS TO UPDATE THE 'ADMINISTERED BY' OFFICE AND PROVIDE INCREMENTAL FUNDING TO CLINS 1002 AND 1012. |
| Mar 25, 2025 | P00011 | $25.0K | THE PURPOSE OF THIS MODIFICATION IS TO CORRECTION OF OPTION CLIN 1002 AND 1012 PERIOD OF PERFORMANCE, DE-OBLIGATE FUNDING, EXERCISE AND INCREMENTALLY FUND OPTION YEAR 1 CLINS 1002 AND 1012. |
| Jan 10, 2025 | P00010 | $637.0K | THE PURPOSE OF THE MODIFICATION IS TO PROVIDE INCREMENTAL FUNDING TO CLIN 0012 AND REALIGN CEILING. |
| Dec 19, 2024 | P00009 | $6.5M | THE PURPOSE OF THIS MODIFICATION IS TO ESTABLISH CLINS 0004, 0014, 0024, AND OPTION CLINS 1004, 1014, 1024, 2004, 2014, AND 2024, PROVIDE INCREMENTAL FUNDING, CEILING REALIGNMENT, AND UPDATE THE SOW. |
| Oct 29, 2024 | P00008 | $778.1K | THE PURPOSE OF THIS MODIFICATION IS TO PROVIDE INCREMENTAL FUNDING TO CLIN 0012. |
| Oct 16, 2024 | P00007 | $635.2K | THE PURPOSE OF THIS MODIFICATION IS TO PROVIDE INCREMENTAL FUNDING TO CLIN 0011. |
| Sep 12, 2024 | P00006 | $95.1K | THE PURPOSE OF THIS MODIFICATION IS TO INCREMENTALLY FUND CLINS 0011 AND 0012. |
| Aug 20, 2024 | P00005 | $1.1M | INCREMENTAL FUNDING FOR CLINS 0011 AND 0012, AND ATTACH GSA LETTER OF AUTHORITY. |
| Jul 23, 2024 | P00004 | $160.0K | INC FUNDING |
| Jul 10, 2024 | P00003 | $779.7K | INC FUNDING AND CLAUSE ADDITION. |
| Apr 30, 2024 | P00002 | $3.7M | INCREMENTAL FUNDING |
| Apr 18, 2024 | P00001 | $97.7K | INCREMENTAL FUNDING |
| Mar 22, 2024 | 0 | $3.1M | NEW TASK ORDER UNDER THE BOA FOR THE MMS SUPPORT SERVICES. |
Estimated positioning window
Oct 25, 2026 – Jan 23, 2027
60/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 60/100. Available recorded signals: 55 points.
- Contract end 2027-03-24 (150 days from calculation)
- +35 points
- 1 historical awards in this buyer and category group
- +0 points
- 28 recorded award transactions
- +10 points
- Latest award action: 2026-05-18
- +5 points
- Parent award identifier recorded
- +5 points
- Solicitation identifier recorded
- +0 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-10-25 10:18:04.631876+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Oct 25, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.